U.S. CDC advisers weigh Moderna COVID vaccine for teens, older children

Published by

(Reuters) – Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are meeting on Thursday to decide on the use of Moderna Inc’s COVID-19 vaccine for children and adolescents aged 6 to 17, after months of delay in that age group due to safety concerns. Should they vote to recommend its use, CDC Director Rochelle Walensky must then sign off for the U.S. government to start rolling the Moderna vaccine out for these children and teens. The Pfizer-BioNTech vaccine, based on similar messenger RNA technology, has been available for teens for over a year and for children aged 5-11 sinc…

Read More

Leave a Reply